Huang Ya-Chi, a director at Apollomics Inc., has reported a recent transaction involving the acquisition of shares and the vesting of restricted stock units. This event, filed on November 17, 2026, is significant as it highlights changes in ownership that could affect the company's governance and strategic direction.

Background

Apollomics Inc. operates in the pharmaceutical preparations sector, which is known for its competitive landscape and innovation-driven growth. The company is listed under the Central Index Key (CIK) 0001944885. Recent filings indicate ongoing activity related to ownership changes, with Huang Ya-Chi being a key figure in this context.

What the Filing Says

According to the filing, Huang Ya-Chi acquired 500 Class A ordinary shares on November 17, 2026, bringing their total ownership to 2,000 shares. The transaction was coded as an acquisition (M) with a price of $0 per share. Additionally, 500 restricted stock units (RSUs) vested on the same date, which had been granted earlier in the year. The filing states, "This transaction represents the vesting of 500 RSUs on November 17, 2026." The RSUs were previously reported in earlier filings.

Impact

This development may influence Apollomics Inc.'s corporate governance and strategic initiatives. Shareholder dynamics can play a crucial role in decision-making processes and overall company direction. The pharmaceutical sector often experiences shifts in management and ownership, which can impact competition and innovation.

What's Next

The filing does not say what happens next regarding further transactions or changes in ownership. Stakeholders will be watching for any additional disclosures that may arise from Huang Ya-Chi or Apollomics Inc. in the coming months.